Bulk Inquiry
SK-216
- Soluble in 0.1N NaOH(aq) and DMSO
- MF: C29H31NO6
- MW: 489.56
Description
SK-216 is a specific inhibitor of PAI-1 and limits tumor progression and angiogenesis. SK-216 could suppress PAI-1 expression in rat colon cancer cells as well as intestinal polyp formation in a Min mouse. Furthermore, SK-216 could inhibit lung metastasis of human lung cancer cells and mouse melanoma cells in an intravenously-injected mouse mode. Potential novel anti-metastasis agent for human osteosarcoma.
More Information
| Parent CAS No. | 654080-02-1 |
|---|---|
| Chemical Name | 2-(5-(6-(5-tert-Butylbenzo[d]oxazol-2-yl)naphthalen-2-yloxy)pentyl)malonic acid |
| SMILES | C1C=C2C=C(OCCCCCC(C(=O)O)C(=O)O)C=CC2=CC=1C1OC2=CC=C(C(C)(C)C)C=C2N=1 |
| MFCD | N.A. |
| InChi | InChI=1S/C29H31NO6/c1-29(2,3)21-11-13-25-24(17-21)30-26(36-25)20-9-8-19-16-22(12-10-18(19)15-20)35-14-6-4-5-7-23(27(31)32)28(33)34/h8-13,15-17,23H,4-7,14H2,1-3H3,(H,31,32)(H,33,34) |
| InChiKey | FTSCFVVSJVAFEZ-UHFFFAOYSA-N |
| CID | 23624303 |
| Short Description | PAI-1 inhibitor |
References
- M Mutoh et al. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Carcinogenesis. 2008 Apr;29(4):824-9.
- T Masuda et al. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis. Mol Cancer Ther. 2013 Nov;12(11):2378-88.
- M Tsuge et al. SK-216, a Novel Inhibitor of Plasminogen Activator Inhibitor-1, Suppresses Lung Metastasis of Human Osteosarcoma. Int J Mol Sci. 2018 Mar 5;19(3). pii: E736.
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.


